Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 12:44 AM
NCT ID:
NCT04853667
Eligibility Criteria:
Inclusion Criteria:
* Francophone children and adolescents with hereditary epidermolysis bullosa and of an age to express themselves verbally
* French-speaking holders of parental authority
* Regular follow-ups at the reference center for genetic diseases with cutaneous expression (MAGEC), dermatology department of Necker hospital
* Pain at the time of treatment, the evaluation of which is greater than 4/10 (visual analogue scale VAS) without taking weak or strong opioid analgesics, yet prescribed as premedication
* Holders of parental authority and patients informed and not opposing their participation in the study
Exclusion Criteria:
* Children and adolescents without pain at the time of treatment or for whom paracetamol is sufficient to obtain good pain control
* Children and adolescents already taking analgesic treatments even if their pain is not well balanced at the time of care
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Study:
NCT04853667
Study Brief:
Protocol Section:
NCT04853667